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Intracranial pressure (ICP) monitoring is considered the
standard of care for severe traumatic brain injury (TBI)
and is used frequently, but the efficacy of treatment
based on monitoring in improving the outcome has not
been rigorously assessed.Methods
Objective: The objective was to compare efficacy of
guideline-based management in which a protocol for
monitoring intraparenchymal ICP was used (ICP group)
or a protocol in which treatment was based on imaging
and clinical examination (exam group).
Design: A multicenter randomized controlled trial was
conducted.
Setting: The trial was set in ICUs in Bolivia or Ecuador.
Subjects: Patients had severe TBI (n = 324) and were 13
years of age or older.
Interventions: Patients were randomly allocated to ICP
monitoring or clinical exam-based monitoring.
Outcomes: The primary outcome was a composite of
survival time, impaired consciousness, functional status
at 3 and 6 months, and neuropsychological status at 6
months; neuropsychological status was assessed by an
examiner who was unaware of the protocol assignment.* Correspondence: kaynarm@upmc.edu
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© BioMed Central Ltd.2014This composite measure was based on performance
across 21 measures of functional and cognitive status
and was calculated as a percentile (with 0 indicating the
worst performance, and 100 the best performance).
Results
There was no significant between-group difference in the
primary outcome, a composite measure based on percentile
performance across 21 measures of functional and cogni-
tive status (score 56 in the pressure-monitoring group ver-
sus 53 in the imaging-clinical examination group; P = 0.49).
Six-month mortality rates were 39% in the pressure-
monitoring group and 41% in the imaging-clinical examin-
ation group (P = 0.60). The median lengths of stay in the
ICU were similar in the two groups (12 days in the
pressure-monitoring group and 9 days in the imaging-
clinical examination group; P = 0.25), although the number
of days of brain-specific treatments (for example, adminis-
tration of hyperosmolar fluids and the use of hyperventila-
tion) in the ICU was higher in the imaging-clinical
examination group than in the pressure-monitoring group
(4.8 versus 3.4, P = 0.002). The distributions of serious ad-
verse events were similar in the two groups.
Conclusions
For patients with severe TBI, care focused on maintaining
monitored ICP at 20 mmHg or less was not shown to be
superior to care based on imaging and clinical examination.
Commentary
Traumatic brain injury (TBI) causes significant morbid-
ity and mortality in the US, with 1.7 million TBIs ac-
counting for 275,000 hospitalizations and 52,000 deaths
annually [1]. At least 5.3 million Americans currently
live with TBI-related disabilities, with an estimated $60.4
billion in direct and indirect costs [2,3].
Many interventions have been investigated to reduce
TBI-associated sequelae. One such intervention is invasive
intracranial pressure (ICP) monitoring, which is important
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outcomes [4]. The most recent guidelines for TBI manage-
ment recommend ICP monitoring in select patients [5].
Invasive ICP monitoring is not without risks, such as
infection, hemorrhage, malfunction, and additional costs.
As with any monitoring in the intensive care unit, the
goal is to both obtain accurate data and initiate interven-
tions that positively affect outcomes.
Several single-center and multicenter observational
studies have shown that ICP-targeted management of TBI
is associated with worse outcomes, including prolonged
mechanical ventilation, worse functional status, and
higher risk of pneumonia, acute kidney injury, and mortal-
ity [6-8]. However, the results of these studies may be
biased because they were retrospective and sicker patients
may be more likely to receive ICP monitoring.
Chesnut and colleagues conducted a prospective ran-
domized clinical trial to determine whether ICP monitor-
ing improves outcomes. Since invasive ICP monitoring is
considered standard of care, this study would have lacked
clinical equipoise if conducted in the United States. There-
fore, this study had to be conducted in centers that devi-
ated from this ‘standard’. The authors recruited patients
from Bolivia and Ecuador, where ICP monitoring was not
the standard of care. The authors concluded that ICP-
guided care was not superior to care based on imaging
and clinical exam alone, contrary to published guidelines.
The study results suggest that management of TBI
based on invasive monitoring with a goal ICP of not
more than 20 mmHg was not superior to management
based on imaging and clinical exam alone, thus ques-
tioning the added risks of invasive ICP monitoring. Since
this may significantly impact clinical practice patterns, a
detailed assessment of the study and results must be
undertaken.
Strengths of this study include its randomized, pro-
spective nature as well as the comprehensive nature of
the endpoint measured, which factored in measure-
ments of in-hospital morbidity and quality of life after
discharge.
This study has limitations. First, the authors did not
report differences in pre-hospital care or care after hos-
pital discharge. Although the study was randomized,
there may have been important differences in care, in-
cluding pre-hospital transport times and management
and post-discharge care and rehabilitation. Unfortunately,
this information is not provided in the article and may
confound the results.
Second, the authors used a composite primary end-
point. They attempted to incorporate measurements of
many quality-of-life issues, including mortality, cognitive
impairment, and motor impairment. They produced an
original, thoughtful, and complex, yet unvalidated, com-
posite tool to measure TBI outcomes.Third, they assessed therapeutic intensity as a secondary
outcome and calculated it based on an original scoring
system that bears some resemblance to the Therapeutic
Intensity Level Scoring System [9] and Pediatric Intensity
Level of Therapy Scoring System [10]. Based on this scale,
the groups received different intensities of therapeutic
interventions, with the control group receiving more
treatment with mannitol, hypertonic saline, and hyperven-
tilation (P < 0.001). However, the ICP group was noted to
have increased barbiturate use (P = 0.02). What weights to
assign these different interventions in a measure of treat-
ment intensity is open to debate. Furthermore, detailed re-
view of the protocols applied to the two groups shows
small but key differences. For example, the first interven-
tion for elevated ICP in the monitored group was to drain
cerebrospinal fluid (CSF) if a ventriculostomy was in place,
which was not an option in the exam group. The ICP
group had 346 hours of CSF drainage, but according to a
personal communication with the author, the majority of
this was in a single patient who had intraventricular blood
and was clearly an outlier. Other differences included the
use of neuromuscular blocking agents in the ICP group
and furosemide in the exam group. The results of the
study would have been more robust had these differences
been minimized. Finally, no information regarding the
number of head computed tomography scans performed
in each group was provided. Although the author stated
there was not a significant difference (personal communi-
cation), this raises the question of additional radiation ex-
posure and increased hospital costs.
An important question is whether the findings of this
study can be generalized to other countries. There are
differences in pre-hospital care, in-hospital management
of patients with TBI, and rehabilitation services across
different countries, and these differences may affect out-
comes. Although invasive ICP monitoring did not affect
outcomes in resource-poor settings, whether it improves
outcomes in resource-rich countries is not known.
This trial is to be commended for its courage in ques-
tioning a therapy that has gained widespread acceptance
as the ‘standard of care’ as well as its attempt to study
this monitoring modality in a randomized controlled
fashion. Though not providing a definitive answer as to
whether ICP monitoring improves outcomes, it adds to
the discussion in a thought-provoking way. ICP may rep-
resent a non-specific marker of dynamic brain pathology
that draws attention to dynamic changes occurring in
the brain, and both waveform analysis and cerebrovascu-
lar reactivity index can be derived from ICP monitoring,
which may help guide therapy [11]. Moreover, the present
study highlights the importance of clinical examinations in
patient management, reminding us that reliance on moni-
tors and measured parameters should not substitute for clin-
ical acumen. Chesnut himself states in a commentary that
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course, and its response to treatment is much preferable to
treating semi-empirically’ [12]. To this end, invasive ICP
monitoring is better viewed as a tool providing another piece
of data for the clinician to take into account and not as an
endpoint in and of itself dictating treatment.
Recommendation
There is insufficient evidence at this time to abandon
treatment based on ICP monitoring, and further studies
need to be done before changing practice. ICP monitor-
ing must be used as part of a multimodal approach to
the patient and viewed as an additional tool available to
the clinician to manage patients with TBI.
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